Literature DB >> 18559907

Autosomal recessive hypophosphatasia manifesting in utero with long bone deformity but showing spontaneous postnatal improvement.

David A Stevenson1, John C Carey, Stephen P Coburn, Karen L Ericson, Janice L B Byrne, Steven Mumm, Michael P Whyte.   

Abstract

CONTEXT: Hypophosphatasia (HPP) is a heritable metabolic disorder of the skeleton that includes variable expressivity conditioned by gene dosage effect and the variety of mutations in the tissue nonspecific alkaline phosphatase (TNSALP) gene. Patient age when skeletal problems first manifest generally predicts the clinical course, with perinatal HPP causing bone disease in utero with postnatal lethality.
OBJECTIVE: Our objective was to identify TNSALP mutations and characterize the inheritance pattern of a family with clinically variable HPP with one child manifesting in utero with long bone deformity but showing spontaneous prenatal and postnatal improvement.
DESIGN: TNSALP enzyme and substrate analysis and TNSALP mutation analysis were performed on all family members. PATIENTS: A boy with HPP showing long bone deformity that spontaneously improved in utero and after birth is described. His older brother has the childhood form of HPP without findings until after infancy. His parents and twin sister are clinically unaffected.
RESULTS: Both boys are compound heterozygotes for the same missense mutations in TNSALP, documenting autosomal recessive inheritance for their HPP. The parents each carry one defective allele.
CONCLUSIONS: The patient is an autosomal recessive case of HPP with prenatal long bone deformity but with spontaneous prenatal and postnatal improvement. Thus, prenatal detection by sonography of bowing of long bones from HPP, even with autosomal recessive inheritance, does not necessarily predict lethality but can represent variable expressivity or the effects of modifiers on the TNSALP defect(s).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559907      PMCID: PMC2567856          DOI: 10.1210/jc.2008-0318

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

1.  Mild hypophosphatasia mimicking severe osteogenesis imperfecta in utero: bent but not broken.

Authors:  R M Pauli; P Modaff; S L Sipes; M P Whyte
Journal:  Am J Med Genet       Date:  1999-10-29

2.  Hypophosphatasia.

Authors:  D FRASER
Journal:  Am J Med       Date:  1957-05       Impact factor: 4.965

3.  The excretion of phosphoethanolamine and hypophosphatasia.

Authors:  R A McCANCE; A B MORRISON; C E DENT
Journal:  Lancet       Date:  1955-01-15       Impact factor: 79.321

4.  Mild hypophosphatasia in utero: bent bones in a family with dental disease.

Authors:  Christine Comstock; Richard Bronsteen; Wesley Lee; Ivana Vettraino
Journal:  J Ultrasound Med       Date:  2005-05       Impact factor: 2.153

5.  Mild autosomal dominant hypophosphatasia: in utero presentation in two families.

Authors:  C A Moore; C J Curry; P S Henthorn; J A Smith; J C Smith; P O'Lague; S P Coburn; D D Weaver; M P Whyte
Journal:  Am J Med Genet       Date:  1999-10-29

Review 6.  Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization.

Authors:  M P Whyte
Journal:  Endocr Rev       Date:  1994-08       Impact factor: 19.871

7.  Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia.

Authors:  Toshimi Michigami; Takayuki Uchihashi; Akira Suzuki; Kanako Tachikawa; Shigeo Nakajima; Keiichi Ozono
Journal:  Eur J Pediatr       Date:  2005-01-20       Impact factor: 3.183

8.  Correlations of genotype and phenotype in hypophosphatasia.

Authors:  L Zurutuza; F Muller; J F Gibrat; A Taillandier; B Simon-Bouy; J L Serre; E Mornet
Journal:  Hum Mol Genet       Date:  1999-06       Impact factor: 6.150

9.  Analysis of localization of mutated tissue-nonspecific alkaline phosphatase proteins associated with neonatal hypophosphatasia using green fluorescent protein chimeras.

Authors:  G Cai; T Michigami; T Yamamoto; N Yasui; K Satomura; M Yamagata; M Shima; S Nakajima; S Mushiake; S Okada; K Ozono
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

10.  Early prenatal diagnosis of congenital hypophosphatasia: case report.

Authors:  J W Wladimiroff; M F Niermeijer; J J Van der Harten; P A Stewart; F G Versteegh; W Blom; J G Huijmans
Journal:  Prenat Diagn       Date:  1985 Jan-Feb       Impact factor: 3.050

View more
  6 in total

1.  Clinical utility gene card for: hypophosphatasia.

Authors:  Etienne Mornet; Christine Beck; Agnès Bloch-Zupan; Hermann Girschick; Martine Le Merrer
Journal:  Eur J Hum Genet       Date:  2010-10-27       Impact factor: 4.246

2.  Clinical utility gene card for: hypophosphatasia - update 2013.

Authors:  Etienne Mornet; Christine Hofmann; Agnès Bloch-Zupan; Hermann Girschick; Martine Le Merrer
Journal:  Eur J Hum Genet       Date:  2013-08-07       Impact factor: 4.246

Review 3.  Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy.

Authors:  Jean Pierre Salles
Journal:  Clin Biochem Rev       Date:  2020-02

4.  Large-scale in vitro functional testing and novel variant scoring via protein modeling provide insights into alkaline phosphatase activity in hypophosphatasia.

Authors:  Guillermo Del Angel; John Reynders; Christopher Negron; Thomas Steinbrecher; Etienne Mornet
Journal:  Hum Mutat       Date:  2020-03-18       Impact factor: 4.878

5.  The Clinical Picture of Patients Suffering from Hypophosphatasia-A Rare Metabolic Disease of Many Faces.

Authors:  Izabela Michałus; Aneta Gawlik; Katarzyna Wieczorek-Szukała; Andrzej Lewiński
Journal:  Diagnostics (Basel)       Date:  2022-03-30

6.  Genotype-Phenotype Associations in 72 Adults with Suspected ALPL-Associated Hypophosphatasia.

Authors:  Nico Maximilian Jandl; Tobias Schmidt; Tim Rolvien; Julian Stürznickel; Konstantin Chrysostomou; Emil von Vopelius; Alexander E Volk; Thorsten Schinke; Christian Kubisch; Michael Amling; Florian Barvencik
Journal:  Calcif Tissue Int       Date:  2020-11-15       Impact factor: 4.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.